Thermo, Fisher Shareholders Approve Merger; Regulatory OK Still Sought | GenomeWeb
NEW YORK (GenomeWeb News) – Thermo Electron and Fisher Scientific International today said that their shareholders have approved their merger.
 
The companies said that the deal, the largest ever in the biotech industry, remains subject to regulatory approval.
 
As GenomeWeb News reported this week, Fisher said it would divest an undisclosed product line to satisfy the Federal Trade Commission.  The line is worth $17 million, Fisher said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.